Literature DB >> 25592986

Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation.

Bruce S Bochner1, Nives Zimmermann2.   

Abstract

Virtually all cells and extracellular material are heavily decorated by various glycans, yet our understanding of the structure and function of these moieties lags behind the understanding of nucleic acids, lipids, and proteins. Recent years have seen a tremendous acceleration of knowledge in the field of glycobiology, revealing many intricacies and functional contributions that were previously poorly appreciated or even unrecognized. This review highlights several topics relevant to glycoimmunology in which mammalian and pathogen-derived glycans displayed on glycoproteins and other scaffolds are recognized by specific glycan-binding proteins (GBPs), leading to a variety of proinflammatory and anti-inflammatory cellular responses. The focus for this review is mainly on 2 families of GBPs, sialic acid-binding immunoglobulin-like lectins (siglecs) and selectins, that are involved in multiple steps of the immune response, including distinguishing pathogens from self, cell trafficking to sites of inflammation, fine-tuning of immune responses leading to activation or tolerance, and regulation of cell survival. Importantly for the clinician, accelerated rates of discovery in the field of glycoimmunology are being translated into innovative medical approaches that harness the interaction of glycans and GBPs to the benefit of the host and might soon lead to novel diagnostics and therapeutics.
Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Siglec; dectin; glycan; glycan-binding proteins; glycobiology; selectin; sialic acid; treatment

Mesh:

Substances:

Year:  2015        PMID: 25592986      PMCID: PMC4355302          DOI: 10.1016/j.jaci.2014.11.031

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  112 in total

1.  Mechanism of Siglec-8-induced human eosinophil apoptosis: role of caspases and mitochondrial injury.

Authors:  Esra Nutku; Sherry A Hudson; Bruce S Bochner
Journal:  Biochem Biophys Res Commun       Date:  2005-10-28       Impact factor: 3.575

2.  Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors:  Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2006-08-04       Impact factor: 47.728

Review 3.  Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.

Authors:  Takumi Kiwamoto; Norihito Kawasaki; James C Paulson; Bruce S Bochner
Journal:  Pharmacol Ther       Date:  2012-06-27       Impact factor: 12.310

4.  Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.

Authors:  A Samuelsson; T L Towers; J V Ravetch
Journal:  Science       Date:  2001-01-19       Impact factor: 47.728

Review 5.  The impact of glycosylation on the biological function and structure of human immunoglobulins.

Authors:  James N Arnold; Mark R Wormald; Robert B Sim; Pauline M Rudd; Raymond A Dwek
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

6.  CD24 and Siglec-10 selectively repress tissue damage-induced immune responses.

Authors:  Guo-Yun Chen; Jie Tang; Pan Zheng; Yang Liu
Journal:  Science       Date:  2009-03-05       Impact factor: 47.728

7.  Anti-Siglec-F antibody inhibits oral egg allergen induced intestinal eosinophilic inflammation in a mouse model.

Authors:  Dae Jin Song; Jae Youn Cho; Marina Miller; Wendy Strangman; Mai Zhang; Ajit Varki; David H Broide
Journal:  Clin Immunol       Date:  2009-01-08       Impact factor: 3.969

8.  Immunization with recombinantly expressed glycan antigens from Schistosoma mansoni induces glycan-specific antibodies against the parasite.

Authors:  Nina Salinger Prasanphanich; Anthony E Luyai; Xuezheng Song; Jamie Heimburg-Molinaro; Msano Mandalasi; Megan Mickum; David F Smith; A Kwame Nyame; Richard D Cummings
Journal:  Glycobiology       Date:  2014-04-11       Impact factor: 4.313

9.  Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice.

Authors:  Tomomi Toubai; Guoqing Hou; Nathan Mathewson; Chen Liu; Ying Wang; Katherine Oravecz-Wilson; Emily Cummings; Corinne Rossi; Rebecca Evers; Yaping Sun; Julia Wu; Sung Won Choi; Dexing Fang; Pan Zheng; Yang Liu; Pavan Reddy
Journal:  Blood       Date:  2014-04-02       Impact factor: 22.113

Review 10.  Emerging principles for the therapeutic exploitation of glycosylation.

Authors:  Martin Dalziel; Max Crispin; Christopher N Scanlan; Nicole Zitzmann; Raymond A Dwek
Journal:  Science       Date:  2014-01-03       Impact factor: 47.728

View more
  35 in total

1.  Immortalized MH-S cells lack defining features of primary alveolar macrophages and do not support mouse pneumovirus replication.

Authors:  Todd A Brenner; Tyler A Rice; Erik D Anderson; Caroline M Percopo; Helene F Rosenberg
Journal:  Immunol Lett       Date:  2016-02-23       Impact factor: 3.685

Review 2.  Glycans and glycan-binding proteins in immune regulation: A concise introduction to glycobiology for the allergist.

Authors:  Ronald L Schnaar
Journal:  J Allergy Clin Immunol       Date:  2015-01-30       Impact factor: 10.793

3.  Erythrocyte sialoglycoproteins engage Siglec-9 on neutrophils to suppress activation.

Authors:  Anel Lizcano; Ismael Secundino; Simon Döhrmann; Ross Corriden; Cristina Rohena; Sandra Diaz; Pradipta Ghosh; Lingquan Deng; Victor Nizet; Ajit Varki
Journal:  Blood       Date:  2017-04-17       Impact factor: 22.113

4.  Tissue-Specific Glycosylation at the Glycopeptide Level.

Authors:  Katalin F Medzihradszky; Krista Kaasik; Robert J Chalkley
Journal:  Mol Cell Proteomics       Date:  2015-05-20       Impact factor: 5.911

Review 5.  "Siglec"ting the allergic response for therapeutic targeting.

Authors:  Bruce S Bochner
Journal:  Glycobiology       Date:  2016-02-23       Impact factor: 4.313

Review 6.  Sialic acid-binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses.

Authors:  Heinz Läubli; Ajit Varki
Journal:  Cell Mol Life Sci       Date:  2019-09-04       Impact factor: 9.261

7.  Expression of ligands for Siglec-8 and Siglec-9 in human airways and airway cells.

Authors:  Yi Jia; Huifeng Yu; Steve M Fernandes; Yadong Wei; Anabel Gonzalez-Gil; Mary G Motari; Katarina Vajn; Whitney W Stevens; Anju T Peters; Bruce S Bochner; Robert C Kern; Robert P Schleimer; Ronald L Schnaar
Journal:  J Allergy Clin Immunol       Date:  2015-03       Impact factor: 10.793

8.  Development and characterization of a stable bovine intestinal sub-epithelial myofibroblast cell line from ileum of a young calf.

Authors:  Tirth Uprety; Brionna B Spurlin; Linto Antony; Chithra Sreenivasan; Alan Young; Feng Li; Michael B Hildreth; Radhey S Kaushik
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-06-10       Impact factor: 2.416

9.  Siglec-7 on peripheral blood eosinophils: Surface expression and function.

Authors:  Fanny Legrand; Nadine Landolina; Ilan Zaffran; Robert O Emeh; Elizabeth Chen; Amy D Klion; Francesca Levi-Schaffer
Journal:  Allergy       Date:  2019-02-26       Impact factor: 13.146

10.  Regulation of Siglec-8-induced intracellular reactive oxygen species production and eosinophil cell death by Src family kinases.

Authors:  Gen Kano; Bruce S Bochner; Nives Zimmermann
Journal:  Immunobiology       Date:  2016-09-20       Impact factor: 3.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.